PL446676A1 - E-cigarette liquid composition and e-cigarette containing such composition - Google Patents

E-cigarette liquid composition and e-cigarette containing such composition

Info

Publication number
PL446676A1
PL446676A1 PL446676A PL44667623A PL446676A1 PL 446676 A1 PL446676 A1 PL 446676A1 PL 446676 A PL446676 A PL 446676A PL 44667623 A PL44667623 A PL 44667623A PL 446676 A1 PL446676 A1 PL 446676A1
Authority
PL
Poland
Prior art keywords
cigarette
composition
liquid composition
cigarette liquid
cigarette containing
Prior art date
Application number
PL446676A
Other languages
Polish (pl)
Inventor
Dmitrii Shesternenko
Original Assignee
Dmitrii Shesternenko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmitrii Shesternenko filed Critical Dmitrii Shesternenko
Priority to PL446676A priority Critical patent/PL446676A1/en
Priority to PCT/IB2024/061134 priority patent/WO2025099687A1/en
Publication of PL446676A1 publication Critical patent/PL446676A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Przedmiotem niniejszego zgłoszenia jest kompozycja płynu do e-papierosa zawierająca wodę jako jedyny lub główny nośnik substancji aktywnej i aromatu oraz zasadniczo nie zawierająca glikolu propylenowego ani gliceryny oraz e-papieros zawierający taką kompozycję.The subject of the present application is an e-cigarette liquid composition comprising water as the sole or main carrier for the active substance and flavour and substantially free of propylene glycol or glycerin, and an e-cigarette containing such a composition.

PL446676A 2023-11-08 2023-11-08 E-cigarette liquid composition and e-cigarette containing such composition PL446676A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL446676A PL446676A1 (en) 2023-11-08 2023-11-08 E-cigarette liquid composition and e-cigarette containing such composition
PCT/IB2024/061134 WO2025099687A1 (en) 2023-11-08 2024-11-08 Liquid composition for e-cigarette and e-cigarette containing such composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL446676A PL446676A1 (en) 2023-11-08 2023-11-08 E-cigarette liquid composition and e-cigarette containing such composition

Publications (1)

Publication Number Publication Date
PL446676A1 true PL446676A1 (en) 2025-05-12

Family

ID=95653662

Family Applications (1)

Application Number Title Priority Date Filing Date
PL446676A PL446676A1 (en) 2023-11-08 2023-11-08 E-cigarette liquid composition and e-cigarette containing such composition

Country Status (2)

Country Link
PL (1) PL446676A1 (en)
WO (1) WO2025099687A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112617272A (en) * 2019-10-09 2021-04-09 普济生物科技（台州）有限公司 Electronic cigarette tobacco tar of water matrix atomized liquid
CN113057365A (en) * 2021-03-21 2021-07-02 浙江普绿世新材料科技有限公司 Water-based atomized liquid for electronic cigarette
EP3906794A1 (en) * 2019-01-25 2021-11-10 China Tobacco Hunan Industrial Co., Ltd. Water-based electronic cigarette liquid
WO2023116047A1 (en) * 2021-12-22 2023-06-29 Shenzhen Fumiao Biotechnology Co., Ltd Water-based atomizing agent, water-based atomizing substance for specified purpose, cartomizer and atomizing device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery
CA3209534A1 (en) * 2021-02-24 2022-09-01 Karen V. Taluskie Aerosol precursor formulations
CN115736322B (en) * 2022-12-09 2026-04-24 深圳市真味生物科技有限公司 A method for reducing small-diameter aerosol particles: an atomizing base liquid, an atomizing fluid, and a method for reducing aerosol particles.
CN118787123A (en) * 2023-04-14 2024-10-18 思摩尔国际控股有限公司 A water-based electronic cigarette aerosol preparation and its preparation method and application

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3906794A1 (en) * 2019-01-25 2021-11-10 China Tobacco Hunan Industrial Co., Ltd. Water-based electronic cigarette liquid
CN112617272A (en) * 2019-10-09 2021-04-09 普济生物科技（台州）有限公司 Electronic cigarette tobacco tar of water matrix atomized liquid
CN113057365A (en) * 2021-03-21 2021-07-02 浙江普绿世新材料科技有限公司 Water-based atomized liquid for electronic cigarette
WO2023116047A1 (en) * 2021-12-22 2023-06-29 Shenzhen Fumiao Biotechnology Co., Ltd Water-based atomizing agent, water-based atomizing substance for specified purpose, cartomizer and atomizing device

Also Published As

Publication number Publication date
WO2025099687A1 (en) 2025-05-15

Similar Documents

Publication Publication Date Title
CL2021003191A1 (en) Tead inhibitors and uses thereof
MX2020007945A (en) Stabilized rsv f proteins and uses thereof.
RU2013137460A (en) METHOD FOR PAINTING OR LIGHTENING KERATIN FIBERS IN TWO RECEPTIONS USING DIRECT ALKALINE EMULSION ENRICHED OIL ON THE BASIS OF SOLID NON-IONOGENOUS HUMAN RESOURCE HELP 1
MY204641A (en) Multispecific antigen-binding molecule having blood coagulation factor viii (fviii) cofactor function-substituting activity, and pharmaceutical formulation containing said molecule as active ingredient
DOP2012000314A (en) COMPOUNDS, THIOCETATE COMPOSITIONS AND METHODS OF USE
CL2021003105A1 (en) Masp-2 inhibitors and methods of use (divisional application no. 202003083)
EA201890247A1 (en) DEZOXYURIDINTRIPHIPHPHATASI INHIBITORS CONTAINING HYDANTOIN
CR20210270A (en) MIXTURES AND COMPOSITIONS INCLUDING 5-FLUORO-4-IMINO-3-METHYL-1-TOSIL-3,4-DIHYDROPYRIMIDIN-2-ONA, AND METHODS OF USE OF THE SAME
MX2018014631A (en) Liquid neurotoxin formulation stabilized with tryptophan or tyrosine.
EA201991988A1 (en) COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH USING MPC1 INHIBITORS
EA202190261A1 (en) TOPIC OILY COMPOSITIONS
MX2020002347A (en) Use of physiological cooling active ingredients, and compositions comprising such active ingredients.
EA201992721A1 (en) METHODS FOR OBTAINING AND APPLICATION OF PDE9 INHIBITORS
MX2018012941A (en) FORMULATIONS AND METHODS TO TREAT PHOTOSYNTHETIC ORGANISMS AND IMPROVE THE QUALITIES AND AMOUNTS OF PERFORMANCES WITH GLICANO COMPOUND FORMULATIONS.
MX2020001908A (en) Miticide and application thereof.
MX2022007009A (en) Topical composition and methods of measuring the cooling abaility of a topical composition.
PL446676A1 (en) E-cigarette liquid composition and e-cigarette containing such composition
MX2021009142A (en) TOPICAL INHIBITORS OF PHOSPHOINOSITOL 3-KINASES.
MX2021005120A (en) Aerosolised formulation.
CO2021014255A2 (en) Antifungal compositions
MA37880A1 (en) Transdermal formulation containing cox inhibitors
MX374621B (en) PERFUME COMPOSITION.
MX2021008071A (en) Substituted fused imidazole derivatives and methods of treating sickle cell disease and related complications.
EA202190695A1 (en) COMPOSITION OF SURFACE-ACTIVE SUBSTANCES AND ITS APPLICATION
CO2017008372A2 (en) Derivatives of (2r) -3-amino-2- (bi-cyclicpyridylmethyl) -2-hydroxy-propanoic acid as p-lap inhibitors